Skip to main content
TipRanks
Go Ultimate75% OFF

Cencora (0HF3) Share Price & Analysis

0 Followers

0HF3 Stock Chart & Stats

$356.09$6.54(1.87%)
At close: 4:30 PM GMT
$300$325$350Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$349.40 - $356.96
52-Week Range
$245.77 - $381.28
Previous Close
$349.55
Volume
N/A
Average Volume (3M)
2,253
Market Cap
$68.51B
Enterprise Value
$63.96B
Total Cash (Recent Filing)
$4.88B
Total Debt (Recent Filing)
$11.27B
Price to Earnings (P/E)
20.0
Beta
0.65
Next Earnings
Feb 03, 2027 (Est.)
Dividend Yield
0.69%

Bulls Say, Bears Say

Bulls Say

Record Operating Performance

Record operating income and earnings growth indicate that Cencora is converting its large distribution platform into improving profitability. The combination of scale, stronger execution, and better earnings conversion supports continued investment and reinforces the company’s ability to compound results over multiple quarters.

Specialty Platform Expansion

Cencora is positioned in a faster-growing specialty market through distribution, provider services, oncology, retina, and clinical-trial capabilities. This broader platform can deepen customer relationships, support higher-value services, and provide a durable growth engine beyond traditional pharmaceutical distribution.

Strong Cash Generation

Substantial free cash flow gives Cencora flexibility to fund infrastructure, specialty expansion, acquisitions, debt service, and shareholder returns. The ability to generate cash at this scale strengthens strategic execution and provides an internal funding source for the company’s long-term growth priorities.

Bears Say

Elevated Leverage

Cencora’s debt-heavy capital structure increases sensitivity to interest costs, refinancing conditions, and working-capital swings. Although equity has improved from negative levels, elevated leverage can constrain financial flexibility and make acquisitions or shareholder returns more dependent on sustained cash generation.

Structurally Thin Margins

Very thin margins are inherent to Cencora’s distribution model but leave limited protection if operating costs, pricing pressure, or product mix weaken. Small changes in gross profit can therefore have an outsized effect on earnings, making sustained efficiency and specialty mix improvement important to long-term profitability.

Moderating Growth Outlook

The expected slowdown from fiscal 2026’s stronger performance suggests that near-term growth is becoming less broad-based. Moderation in consolidated revenue and operating income can reduce operating leverage, while portfolio changes and business headwinds make it harder for the distribution franchise to maintain its recent pace.

Cencora News

0HF3 FAQ

What was Cencora’s price range in the past 12 months?
Cencora lowest share price was $245.77 and its highest was $381.28 in the past 12 months.
What is Cencora’s market cap?
Cencora’s market cap is $68.51B.
When is Cencora’s upcoming earnings report date?
Cencora’s next earnings report is estimated for Feb 03, 2027 (not yet confirmed), which is in 79 days.
How were Cencora’s earnings last quarter?
Cencora released its earnings results on Nov 04, 2026. The company reported $4.66 earnings per share for the quarter, beating the consensus estimate of $4.581 by $0.079.
Is Cencora overvalued?
According to Wall Street analysts Cencora’s price is currently Undervalued.
Does Cencora pay dividends?
Cencora pays a quarterly dividend of $0.66 which represents an annual dividend yield of 0.69%. See more information on Cencora dividends here
What is Cencora’s EPS estimate?
Cencora’s EPS estimate is 4.56.
How many shares outstanding does Cencora have?
Cencora has 190,827,160 shares outstanding.
What happened to Cencora’s price movement after its last earnings report?
Cencora reported an EPS of $4.66 in its last earnings report, beating expectations of $4.581. Following the earnings report the stock price went up 3.107%.
Which hedge fund is a major shareholder of Cencora?
Hedge funds hold Cencora shares: the largest hedge-fund position in Cencora is 1,243,005,412 shares, and hedge funds increased their holdings by 75.7K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology